Also, what does 'reasonable financial compensation' mean? Consider newly patented drugs. The R&D cost is enormous, even without covering the cost of the attempts that failed to get to market. And there can be multiple patents, including the method of action and the method of synthesis.
If you have 5 patents for drug X and I infringe on 3 to make a competing drug X', do I pay less than if I infringe on all 5 patents?
(Edit after several people commented: I believe that amelius meant to include mandatory RAND-like licensing for first sale. My response should be read in that vein.)
Let's say that you are a patent holder for an über-toaster.
If some company is making über-toasters using your patent, you can stop them from using your patent for their profit. This is what patents for.
If some other company is buying used über-toasters, fixes them and re-sells them, you should not be able to stop them from re-selling fixed über-toasters.
If amelius only meant to include re-selling equipment acquired under a valid patent license, then the phrase "It should at most lead to reasonable financial compensation of the inventors" makes no sense. Were patent rights to follow first-sale doctrine, the patent holder would receive no financial compensation for resale. Which, for the record, is fine with me.
I was remiss in not making that clear in my scenario.
If that's not how the law works, it's how it should work. Actually scratch that, the way it should work is to not have patents at all, since they lost their net benefit to society a long time ago (if they ever had it), but that's a whole other can of worms.
This is unfortunate, because there are plenty of empirical studies showing the benefits and costs of patents (search ssrn.com for "patents" and focus on the studies that use economic data). The upshot is, to date nobody has been able to say the one outweighs the other largely because they are not directly comparable.
http://www.dklevine.com/general/intellectual/againstfinal.ht...
https://news.ycombinator.com/item?id=7890441 https://news.ycombinator.com/item?id=8157206
But computer software and tech startups would be much better off since patents are purely harmful to software innovation.
Which points to one obvious reform.
On the other hand, there are multiple other studies showing how having a patent increases the chances of tech startups of a) receiving VC funding and b) making successful exits. I'd say it's still not clear that the software industry is being harmed more by patents than it is being benefited.
Quoting from http://www.nolo.com/legal-encyclopedia/improvement-patents-n... :
> New Uses for Existing Inventions
> You can also get an improvement patent for an innovation that provides a new use for an existing invention. For example, in 2000, the Federal Circuit allowed a patent for the idea of using Bag Balm -- an ointment normally used to soothe irritated cow udders -- to treat human baldness. The court found it patentable, because it's a new use of a known composition.
Quoting from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146086/ :
> In addition to patent protection for the original compound and method of use, patents directed to new uses and treatment indications can be obtained. Developing new methods of use for identified compounds can be a successful strategy for maximizing research dollars and for increasing the commercial life.
Those sound like it's possible to patent use, in addition to the 'creation of something.'
There are several types of patents listed at http://www.uspto.gov/web/offices/ac/ido/oeip/taf/patdesc.htm . One is a patent on new varieties of plants (see https://en.wikipedia.org/wiki/Plant_Patent_Act_of_1930 ). I don't think that counts as "instructions or the specifications for the creation of some object."
You wrote: "Otherwise, you would need to sign a contract for buying a hammer (assuming it was patented) outlining the allowed uses."
I believe this is almost exactly what's at issue in the NYT article, replacing hammer with ink cartridge.
Before 2006 injunctions were essentially presumed, but now it's pretty hard to get an injunction in a patent case.
Suppose I run a firm that sells custom men's clothing, that has a patent to, say, change color and temperature at the wearer's preference. Each outfit has to be personally tailored by a professional designated by our company.
Now, perhaps a high-end men's clothing retailer begins selling my clothing and tailors it in-house. The quality is comparable and they compensate my company. So far so good, right?
Well, what if quality isnt comparable? What if the stitching was improperly done and felt too tight, or unraveled over time? Even if the customer knew that the "re"-seller wasn't an official associate, the damage to our brand would already be done.
And that's why first sale should be at the discretion of the patent holder.